Belhaven Biopharma
Belhaven Biopharma is a startup headquartered in Chapel Hill, United States, founded in 2020. It has raised at least $32.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Belhaven Biopharma has raised at least $32.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Belhaven Biopharma sits inside the Durham region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Chapel Hill
Related
- Innovation profile of Chapel Hill
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Belhaven Biopharma do?
Belhaven Biopharma is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Belhaven Biopharma raised?
At least $32.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Belhaven Biopharma based?
Belhaven Biopharma is headquartered in Chapel Hill, United States.
When was Belhaven Biopharma founded?
Belhaven Biopharma was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.